Sanofi poised for $4B bond issue

Sanofi-Aventis is set to sell $4 billion in Euro-denominated bonds, divided into two tranches of $2 billion each: one with four-year maturities and the other with seven-year maturities. So far this year, drugmakers have been successful with bond investors on both sides of the Atlantic, with Roche completing record issues in both U.S. and Euro markets. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.